Diabetes
-
FDA Approves Tirzepatide to Reduce Heart Attack Risk in Type 2 Diabetes
The FDA has approved tirzepatide (Mounjaro) for cardiovascular risk reduction, marking a shift from glucose-only control to comprehensive heart protection based on…
-
Why Medicare Documentation Rules Drive Denied Claims for Diabetic Shoes
Missing paperwork accounts for 85.5% of improper Medicare payments for diabetic shoes, highlighting strict compliance hurdles for patients and providers.
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
The landmark trial published in NEJM found Dexcom G7 users achieved 0.9% greater A1C reduction versus routine care, with five more hours…
-
Frederick Banting: Co-Discoverer of Insulin, Nobel Laureate
TORONTO, July 16 — Frederick Banting died in a plane crash in Newfoundland in 1941, but the insulin he helped drag out…
-
How insulin went from dog experiments in 1921 to modern diabetes treatment
WASHINGTON, July 16 — The Association for Diagnostics & Laboratory Medicine, the global scientific and medical professional organization formerly known as the…
-
Diabetic man falls into coma as Siberian ambulance has no fuel amid Russian shortages
A diabetic man slipped into a coma. His wife called for an ambulance. The dispatcher told her to find her own ride.…
-
Community health workers show promise for diabetes, hypertension in Cambodia
PHNOM PENH, June 23 — According to the filing, the record shows a significant interest in exploring the potential of community health…
-
Peer Educators Helped Cambodian Diabetes Patients Lower Blood Sugar and Pressure, Study Finds
PHNOM PENH — The burden sits heaviest on the villages that already have the least. For the Cambodian families who live hours…
-
Diabetes Drugs Show Promise in Treating Addiction and Cravings
A class of medications originally developed for diabetes is now being investigated for a completely different purpose: treating addiction. GLP-1 receptor agonists,…
-
How the GLP-1 Hormone Works and Why It Became a Diabetes and Obesity Drug Target
A hormone first characterized in the 1980s has become the foundation of a major transformation in how physicians manage diabetes and obesity.…
-
FDA Approves Lilly’s Mounjaro, a Once-Weekly Dual-Action Drug for Type 2 Diabetes
Millions of Americans who live with type 2 diabetes now have an additional medication to consider. Tir tirzepatide, cleared by the U.S.…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
AstraZeneca’s Imfinzi Wins FDA Approval for Bladder Cancer Patients
-
How Kazia’s Nuclear PD-L1 Degrader Aims to Overcome Cancer Resistance
-
FDA RMAT and Fast Track Designations Set New Evidence Bar for Cell Therapies
-
How mRNA Technology Is Transforming the Future of Personalized Cancer Vaccines
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
How the 2027 401(k) Limit Increase to $25,500 Changes Retirement Planning
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992